URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Michael Becker

Concepts (231)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Neoplastic Stem Cells
6
2004
40
2.060
Why?
Leukemia, Myeloid, Acute
5
2006
172
1.720
Why?
Hematopoiesis
3
2002
128
0.700
Why?
Hematopoietic Stem Cells
5
2002
196
0.510
Why?
Muscle, Smooth, Vascular
5
1992
336
0.440
Why?
Cell Transformation, Neoplastic
4
2002
134
0.430
Why?
Stem Cells
1
2006
338
0.420
Why?
Leukemia, Myeloid
3
2006
115
0.360
Why?
Gene Expression Regulation, Neoplastic
4
2002
247
0.350
Why?
Neoplasms
1
2006
701
0.340
Why?
alpha Catenin
2
2006
3
0.320
Why?
Thromboxane A2
3
1993
12
0.290
Why?
Leukemia
2
2006
152
0.290
Why?
Transcription Factors
1
2002
659
0.280
Why?
Apoptosis
1
2002
782
0.270
Why?
Tumor Suppressor Protein p53
3
2002
134
0.270
Why?
Receptors, Prostaglandin
2
1992
7
0.260
Why?
Cell Differentiation
3
2006
1021
0.250
Why?
Hematopoietic Stem Cell Transplantation
3
2003
124
0.240
Why?
Animals
13
1992
15647
0.240
Why?
Gene Expression Regulation, Leukemic
2
2010
16
0.240
Why?
Flow Cytometry
3
2006
597
0.230
Why?
Humans
17
1993
35000
0.230
Why?
Mutation
3
2006
1183
0.210
Why?
Signal Transduction
3
1993
1465
0.210
Why?
Receptors, Thrombopoietin
1
2012
7
0.200
Why?
Hydrazines
1
2012
13
0.200
Why?
Bicyclo Compounds, Heterocyclic
1
1992
13
0.200
Why?
Cell Division
4
1992
735
0.200
Why?
Benzoates
1
2012
15
0.200
Why?
Nuclear Proteins
2
2003
333
0.200
Why?
Pyrazoles
1
2012
56
0.200
Why?
Growth Substances
1
1992
96
0.190
Why?
Gene Expression Profiling
2
2009
296
0.190
Why?
Chemokine CCL3
1
2011
19
0.190
Why?
Genome-Wide Association Study
1
2011
22
0.190
Why?
Antigens, CD34
1
2011
51
0.190
Why?
Models, Biological
3
2003
982
0.190
Why?
Thrombocytopenia
1
2012
71
0.190
Why?
Methylprednisolone
1
2011
44
0.190
Why?
Gastrointestinal Tract
1
2011
26
0.190
Why?
Translational Medical Research
1
2011
36
0.190
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
124
0.190
Why?
Down-Regulation
1
1992
227
0.180
Why?
Amifostine
1
2010
25
0.180
Why?
Lymphoma, Large B-Cell, Diffuse
1
2011
72
0.180
Why?
Stem Cell Transplantation
1
2012
108
0.180
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2003
15
0.180
Why?
Lymphoma, Non-Hodgkin
1
2011
105
0.180
Why?
Cell Separation
1
2011
224
0.180
Why?
Cytoprotection
1
2010
35
0.180
Why?
Graft vs Host Disease
1
2011
92
0.180
Why?
Myelopoiesis
1
2010
15
0.180
Why?
PTEN Phosphohydrolase
1
2010
14
0.180
Why?
CCAAT-Enhancer-Binding Proteins
1
2010
15
0.180
Why?
Glucocorticoids
1
2011
159
0.170
Why?
Lymphoma
1
2010
151
0.170
Why?
Osteoblasts
1
2011
228
0.170
Why?
Tumor Markers, Biological
1
2011
221
0.160
Why?
Gene Regulatory Networks
1
2009
6
0.160
Why?
Receptors, Thromboxane
3
1992
4
0.160
Why?
Osteoclasts
1
2011
300
0.160
Why?
Liver
2
2003
870
0.160
Why?
Multipotent Stem Cells
1
2008
12
0.150
Why?
Genes, p16
1
2008
8
0.150
Why?
Prognosis
1
2011
1030
0.150
Why?
Genes, p53
1
2008
50
0.150
Why?
Mice
6
2003
5900
0.150
Why?
DNA Mutational Analysis
1
2008
185
0.150
Why?
Sesquiterpenes
1
2007
19
0.150
Why?
Disease Models, Animal
1
2011
908
0.140
Why?
Transplantation, Autologous
3
2010
136
0.140
Why?
Myeloid Progenitor Cells
1
2006
5
0.140
Why?
Chromosomes, Human, Pair 5
1
2006
9
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
409
0.140
Why?
Chromosome Deletion
1
2006
62
0.140
Why?
Repressor Proteins
2
2003
171
0.130
Why?
Neoplasm Transplantation
1
2006
188
0.130
Why?
Multiple Myeloma
1
2006
73
0.130
Why?
Male
8
1992
18870
0.120
Why?
Inositol Phosphates
3
1992
35
0.120
Why?
Cells, Cultured
5
1992
2367
0.120
Why?
Neoplasm Recurrence, Local
1
2006
272
0.120
Why?
Female
7
1999
19061
0.110
Why?
Brain Neoplasms
1
2006
254
0.110
Why?
Leukemia, B-Cell
1
2002
7
0.110
Why?
Oncogene Proteins, Fusion
1
2002
15
0.100
Why?
Zinc Fingers
1
2002
26
0.100
Why?
Thymus Gland
1
2002
143
0.100
Why?
Proto-Oncogene Proteins
1
2003
261
0.090
Why?
Prostatic Neoplasms
1
2006
548
0.090
Why?
Breast Neoplasms
1
2006
660
0.080
Why?
Arthroplasty, Replacement, Knee
1
1999
20
0.080
Why?
Middle Aged
5
1999
9461
0.080
Why?
Patients
1
1999
43
0.080
Why?
Arthroplasty, Replacement, Hip
1
1999
34
0.080
Why?
Attitude
1
1999
63
0.080
Why?
Adult
5
1999
10906
0.080
Why?
HL-60 Cells
2
2006
47
0.080
Why?
DNA-Binding Proteins
1
2002
661
0.070
Why?
Blotting, Western
2
2006
617
0.070
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2006
513
0.070
Why?
Prostaglandin Endoperoxides, Synthetic
2
1992
4
0.070
Why?
Acute Disease
2
2006
570
0.060
Why?
Fibroblast Growth Factors
1
1994
42
0.060
Why?
Mice, Inbred C57BL
2
2008
1613
0.060
Why?
Treatment Outcome
2
2011
2487
0.060
Why?
Rats
4
1992
4185
0.060
Why?
Phosphorylation
2
1993
754
0.050
Why?
Myosin-Light-Chain Kinase
1
1993
9
0.050
Why?
DNA
3
1992
831
0.050
Why?
Rats, Sprague-Dawley
2
1992
956
0.050
Why?
Fibroblast Growth Factor 2
1
1993
76
0.050
Why?
Protein Kinase C
1
1994
193
0.050
Why?
Vasoconstrictor Agents
1
1992
30
0.050
Why?
Isometric Contraction
1
1992
47
0.050
Why?
Bicyclo Compounds
1
1992
1
0.050
Why?
Thromboxanes
1
1992
7
0.050
Why?
Prostaglandins
1
1992
63
0.050
Why?
Platelet Count
1
2012
46
0.050
Why?
Aged
3
1999
6986
0.050
Why?
Fatty Acids, Unsaturated
1
1992
27
0.050
Why?
Fatal Outcome
1
2012
101
0.050
Why?
Blood
1
1992
92
0.050
Why?
Real-Time Polymerase Chain Reaction
1
2011
22
0.050
Why?
Aorta
1
1992
169
0.050
Why?
Muscle Contraction
1
1993
169
0.050
Why?
Immunocompetence
1
2011
30
0.050
Why?
Hydrogen-Ion Concentration
1
1993
561
0.050
Why?
Injections, Intra-Arterial
1
2011
29
0.050
Why?
Transplantation, Homologous
1
2012
261
0.050
Why?
Imidazoles
1
2011
63
0.050
Why?
Diphosphonates
1
2011
40
0.050
Why?
Remission Induction
1
2011
155
0.050
Why?
Pancytopenia
1
2010
13
0.050
Why?
Bone Density Conservation Agents
1
2011
45
0.050
Why?
Immunoenzyme Techniques
1
2011
220
0.050
Why?
Maximum Tolerated Dose
1
2010
16
0.050
Why?
Melphalan
1
2010
27
0.050
Why?
RNA, Messenger
2
2003
1791
0.050
Why?
Mucositis
1
2010
13
0.050
Why?
Peripheral Blood Stem Cell Transplantation
1
2010
20
0.050
Why?
Medical Records
1
2011
122
0.050
Why?
Drug Resistance
1
2011
97
0.050
Why?
Carmustine
1
2010
35
0.050
Why?
Transplantation Conditioning
1
2010
33
0.050
Why?
Cytarabine
1
2010
82
0.050
Why?
Etoposide
1
2010
73
0.050
Why?
Polymerase Chain Reaction
2
1994
586
0.050
Why?
Frameshift Mutation
1
2010
21
0.040
Why?
Transcription, Genetic
2
1994
795
0.040
Why?
Bone Marrow
1
2011
282
0.040
Why?
Spleen
1
2011
338
0.040
Why?
Zebrafish
1
2010
30
0.040
Why?
Enzyme-Linked Immunosorbent Assay
1
2011
459
0.040
Why?
Survival Rate
1
2011
584
0.040
Why?
Protein Isoforms
1
2010
106
0.040
Why?
Bone Resorption
1
2011
227
0.040
Why?
Survival Analysis
1
2011
575
0.040
Why?
Atrial Fibrillation
1
2010
110
0.040
Why?
Databases, Nucleic Acid
1
2009
4
0.040
Why?
Combined Modality Therapy
1
2010
459
0.040
Why?
Protein Processing, Post-Translational
1
2010
132
0.040
Why?
Cell Proliferation
1
2011
480
0.040
Why?
Exons
1
2008
165
0.040
Why?
Biological Availability
1
2007
39
0.040
Why?
Dose-Response Relationship, Drug
1
2010
1085
0.040
Why?
Drug Design
1
2007
45
0.040
Why?
Cell Count
1
2008
279
0.040
Why?
Severity of Illness Index
1
2011
878
0.040
Why?
U937 Cells
1
2006
16
0.040
Why?
Promoter Regions, Genetic
1
2010
534
0.040
Why?
K562 Cells
1
2006
21
0.040
Why?
Dogs
1
2007
465
0.030
Why?
Hydroxamic Acids
1
2006
19
0.030
Why?
DNA Methylation
1
2006
32
0.030
Why?
Structure-Activity Relationship
1
2007
307
0.030
Why?
Mice, Knockout
1
2010
857
0.030
Why?
In Situ Hybridization, Fluorescence
1
2006
107
0.030
Why?
Antineoplastic Agents
1
2011
598
0.030
Why?
Young Adult
1
2010
1013
0.030
Why?
Postoperative Complications
1
2010
706
0.030
Why?
Infant
1
2011
2102
0.030
Why?
Green Fluorescent Proteins
1
2006
205
0.030
Why?
Myelodysplastic Syndromes
1
2006
129
0.030
Why?
Tumor Cells, Cultured
1
2007
871
0.030
Why?
Sensitivity and Specificity
1
2008
866
0.030
Why?
Retrospective Studies
1
2011
2167
0.030
Why?
Reproducibility of Results
1
2008
859
0.030
Why?
Cell Line, Tumor
1
2006
543
0.030
Why?
Gene Expression Regulation
2
1994
848
0.030
Why?
Oxidative Stress
1
2007
330
0.030
Why?
NF-kappa B
1
2007
405
0.030
Why?
Tumor Suppressor Protein p14ARF
1
2003
6
0.030
Why?
Transfection
1
2006
833
0.030
Why?
Hypertrophy
2
1992
60
0.030
Why?
Child
1
2011
3897
0.030
Why?
Cell Line
1
2006
1554
0.030
Why?
Gene Deletion
1
2003
191
0.030
Why?
Bone Marrow Cells
1
2003
220
0.020
Why?
Bone Marrow Transplantation
1
2003
189
0.020
Why?
Group Practice
1
1999
13
0.020
Why?
Hospitals, General
1
1999
17
0.020
Why?
Orthopedics
1
1999
38
0.020
Why?
Sex Factors
1
1999
561
0.020
Why?
Age Factors
1
1999
1060
0.020
Why?
Prospective Studies
1
1999
1606
0.020
Why?
Phorbol Esters
1
1994
17
0.020
Why?
Questionnaires
1
1999
942
0.010
Why?
Immunoblotting
1
1994
210
0.010
Why?
Quinones
1
1993
12
0.010
Why?
Lactams, Macrocyclic
1
1993
13
0.010
Why?
Benzoquinones
1
1993
15
0.010
Why?
Angiotensin II
1
1994
120
0.010
Why?
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
1
1992
5
0.010
Why?
Thymidine
1
1992
81
0.010
Why?
Dinoprost
1
1992
29
0.010
Why?
Tyrosine
1
1993
133
0.010
Why?
Leucine
1
1992
108
0.010
Why?
Aged, 80 and over
1
1999
2423
0.010
Why?
Protein Kinase Inhibitors
1
1993
91
0.010
Why?
Binding, Competitive
1
1992
201
0.010
Why?
Cytosol
1
1992
186
0.010
Why?
United States
1
1999
2511
0.010
Why?
Up-Regulation
1
1993
344
0.010
Why?
Dinoprostone
1
1992
189
0.010
Why?
Protein Biosynthesis
1
1992
257
0.010
Why?
Kinetics
1
1992
1377
0.010
Why?
Base Sequence
1
1993
1681
0.010
Why?
Molecular Sequence Data
1
1993
1993
0.010
Why?
Calcium
1
1992
1069
0.010
Why?

Visualizations


Becker's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department